The need for a new approach in cholesterol management
By the year 2020, cardiovascular disease will be the world's biggest cause of premature death. As the plasma cholesterol is lowered, the incidence of coronary heart disease (CHD) events is reduced. European data on secondary prevention show that many patients have not had a plasma cholesterol r...
Main Author: | |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
_version_ | 1826284507244789760 |
---|---|
author | Hobbs, R |
author_facet | Hobbs, R |
author_sort | Hobbs, R |
collection | OXFORD |
description | By the year 2020, cardiovascular disease will be the world's biggest cause of premature death. As the plasma cholesterol is lowered, the incidence of coronary heart disease (CHD) events is reduced. European data on secondary prevention show that many patients have not had a plasma cholesterol recorded - even those with a diagnosis of CHD. English data show that only half of patients with a cholesterol measurement are being prescribed a statin, and only half of those are being treated to target. Poor public understanding of this subject area is one obstacle to progress. |
first_indexed | 2024-03-07T01:14:52Z |
format | Journal article |
id | oxford-uuid:8e4f460c-b87e-474a-8306-76f2694610e0 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T01:14:52Z |
publishDate | 2004 |
record_format | dspace |
spelling | oxford-uuid:8e4f460c-b87e-474a-8306-76f2694610e02022-03-26T22:56:48ZThe need for a new approach in cholesterol managementJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8e4f460c-b87e-474a-8306-76f2694610e0EnglishSymplectic Elements at Oxford2004Hobbs, RBy the year 2020, cardiovascular disease will be the world's biggest cause of premature death. As the plasma cholesterol is lowered, the incidence of coronary heart disease (CHD) events is reduced. European data on secondary prevention show that many patients have not had a plasma cholesterol recorded - even those with a diagnosis of CHD. English data show that only half of patients with a cholesterol measurement are being prescribed a statin, and only half of those are being treated to target. Poor public understanding of this subject area is one obstacle to progress. |
spellingShingle | Hobbs, R The need for a new approach in cholesterol management |
title | The need for a new approach in cholesterol management |
title_full | The need for a new approach in cholesterol management |
title_fullStr | The need for a new approach in cholesterol management |
title_full_unstemmed | The need for a new approach in cholesterol management |
title_short | The need for a new approach in cholesterol management |
title_sort | need for a new approach in cholesterol management |
work_keys_str_mv | AT hobbsr theneedforanewapproachincholesterolmanagement AT hobbsr needforanewapproachincholesterolmanagement |